Neurological complications after COVID-19: A narrative review
- PMID: 38077923
- PMCID: PMC10700397
- DOI: 10.1016/j.ensci.2023.100485
Neurological complications after COVID-19: A narrative review
Abstract
COVID-19 is primarily classified as a respiratory disorder; however, various neurological symptoms have been reported in COVID-19 patients. Neurological manifestations may be the initial signs of COVID-19 and can develop in patients of different age groups and with or without underlying disease. COVID-19 causes a broad range of complications in the central nervous system. These include headaches, altered mental status, dizziness, seizures, cerebrovascular events, encephalitis, and other encephalopathies. Moreover, a broad spectrum of peripheral nervous system symptoms such as olfactory and gustatory dysfunctions, neuropathy, visual impairments, neuralgia, cranial nerves palsy, and muscle involvement could manifest as symptoms. Despite various efforts, the exact pathogenesis of the COVID-19 neurological complications has not been clarified yet. Moreover, the reason for the development of neurological manifestation in only some COVID-19 patients has not been determined. This review focuses on the different neurological symptoms associated with COVID-19 and the possible pathological mechanisms hoping to provide new insights for diagnosis, therapies, or other forms of intervention.
Keywords: COVID-19; Central nervous system; Peripheral nervous system; SARS-CoV-2.
© 2023 The Authors.
Conflict of interest statement
All authors declare that they have no conflicts of interest and have never published the manuscript.
Similar articles
-
Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19).J Neurol. 2021 Sep;268(9):3059-3071. doi: 10.1007/s00415-021-10406-y. Epub 2021 Jan 23. J Neurol. 2021. PMID: 33486564 Free PMC article. Review.
-
Neurological Manifestations in COVID-19 Patients: A Meta-Analysis.ACS Chem Neurosci. 2021 Aug 4;12(15):2776-2797. doi: 10.1021/acschemneuro.1c00353. Epub 2021 Jul 14. ACS Chem Neurosci. 2021. PMID: 34260855
-
Possible mechanism of central nervous system targeting and neurological symptoms of the new-coronavirus (COVID-19): literature review.Eur Rev Med Pharmacol Sci. 2023 Oct;27(19):9420-9428. doi: 10.26355/eurrev_202310_33970. Eur Rev Med Pharmacol Sci. 2023. PMID: 37843354 Review.
-
Neurological Manifestations in Hospitalized Geriatric Patients With COVID-19 at King Abdulaziz Medical City in Jeddah, Western Region, Saudi Arabia From 2020 to 2021: A Cross-Sectional Study.Cureus. 2023 Sep 22;15(9):e45759. doi: 10.7759/cureus.45759. eCollection 2023 Sep. Cureus. 2023. PMID: 37876390 Free PMC article.
-
Neurological manifestations in COVID-19: A narrative review.SAGE Open Med. 2020 Sep 10;8:2050312120957925. doi: 10.1177/2050312120957925. eCollection 2020. SAGE Open Med. 2020. PMID: 32974019 Free PMC article. Review.
Cited by
-
Reply to: Critical COVID-19 and neurological dysfunction - a direct comparative analysis between SARS-CoV-2 and other infectious pathogens.Crit Care Sci. 2024 Nov 11;36:e20240180en. doi: 10.62675/2965-2774.20240180-en. eCollection 2024. Crit Care Sci. 2024. PMID: 39536209 Free PMC article. No abstract available.
-
SARS-CoV-2, periodontal pathogens, and host factors: The trinity of oral post-acute sequelae of COVID-19.Rev Med Virol. 2024 May;34(3):e2543. doi: 10.1002/rmv.2543. Rev Med Virol. 2024. PMID: 38782605 Free PMC article. Review.
-
A Comprehensive Review on Navigating the Neurological Landscape of COVID-19: Insights Into Etiopathogenesis and Clinical Management.Cureus. 2024 May 11;16(5):e60079. doi: 10.7759/cureus.60079. eCollection 2024 May. Cureus. 2024. PMID: 38860093 Free PMC article. Review.
-
COVID-19 Infection and Associated Outcomes in Patients with Nontraumatic Intracerebral Hemorrhage: Analysis of National Inpatient Sample 2020-2022.Neurocrit Care. 2025 Apr 14. doi: 10.1007/s12028-025-02259-4. Online ahead of print. Neurocrit Care. 2025. PMID: 40229633
-
SARS-CoV-2 Spike Protein Exacerbates Thromboembolic Cerebrovascular Complications in Humanized ACE2 Mouse Model.Transl Stroke Res. 2025 Aug;16(4):1214-1228. doi: 10.1007/s12975-024-01301-5. Epub 2024 Oct 2. Transl Stroke Res. 2025. PMID: 39354270 Free PMC article.
References
-
- Letafati A., Salahi Ardekani O., Karami H., Soleimani M. Ebola virus disease: a narrative review. Microb. Pathog. 2023;181 - PubMed
-
- WHO. 2023.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous